The relationship between hyperinsulinemia, hypertension and progressive renal disease.
about
Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human PathologyRoles of renal proximal tubule transport in acid/base balance and blood pressure regulationA blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathwayCardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic ratsEffects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1.Age-related inflammation and insulin resistance: a review of their intricate interdependencyRapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.Insulin resistance, obesity, hypertension, and renal sodium transport.High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production.Potential Clinical Implications of the Urotensin II Receptor Antagonists.A clinical comparative study of the management of chronic renal failure with Punarnavadi compound.Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)Inflammation and oxidative stress in obesity-related glomerulopathyImplications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.Arterial hypertension in diabetes mellitus: from theory to clinical practice.Coronary artery calcification, ADMA, and insulin resistance in CKD patientsMyocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.Muscle protein synthesis and balance responsiveness to essential amino acids ingestion in the presence of elevated plasma free fatty acid concentrations.Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.Consequences of morbid obesity on the kidney. Where are we going?Hypertension in women: the role of progesterone and aldosterone.Renal involvement and left ventricular hypertrophy are novel risk factors for morbidity and mortality in diabetes mellitus.The effect of weight loss in obesity and chronic kidney disease.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis.Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.Association of Proteinuria and Incident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function.CYP450, COX-2 and Obesity Related Renal Damage.Sodium and water handling after gastric bypass surgery in a rat model.The effect of obesity and type 1 diabetes on renal function in children and adolescents.Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction.Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation.Limited value of routine microalbuminuria assessment in multi-ethnic obese children.Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee.
P2860
Q26781300-22D5778E-E03F-498D-B661-501175563B8EQ26821934-0630F5CB-E566-4C3C-83DA-C3C0F97A5F7EQ27331760-C556A880-BB05-4369-BF67-C7BEDBE01857Q33717027-C3BB2618-B758-45C3-9FED-5CAB58F78121Q33840336-9B8EC15E-6425-4753-8436-1227D77E7CD3Q34466975-48235F5D-9111-4589-B8FD-AB9D8F66D423Q34580477-869702F3-EB9E-4760-AD89-BFCF859896E4Q34633680-C9AB3316-38EF-40AC-8FBB-B8843FF4D388Q34985526-5EE97F05-4B0D-440B-914E-07144C59398DQ35055477-130559DE-747C-4A30-9601-A326833BF07AQ35128456-5D3215F6-386B-432C-ACA6-ED1939EC08CDQ35547793-208F520C-7A34-4D62-936D-F3A1040EED1AQ35612606-D0FAFA6E-165F-4732-83F8-E3C1585FE6CDQ35904102-D152DCD2-7B8A-4AC4-B4DD-29C58649772BQ36390892-C274D918-5930-4E14-AD6A-3AFDF5EFC03AQ36603238-3811D876-95A6-4AB8-A4C6-94C972D627A7Q36766087-E7559DC2-6C6E-4DB6-B752-BFB26FEEA01CQ36843377-C2019523-0259-4092-837B-178ED03BE3C1Q36902706-43F96BE3-F4F8-4CA7-816C-3CE007477787Q36902749-A6EB25B4-16BE-47E2-A9B6-3445447C51A0Q37163138-C7AB92C0-B554-47DA-9145-5EA79271589BQ37315753-75F86704-9AF2-472B-88EC-711A18541ED7Q37362676-79C6D9F9-A267-4C47-9299-A7F4D9E0E78AQ37511029-F562D568-732B-453A-A946-E3162FEFCA53Q37742631-D390B2AB-F069-4EEA-A796-FE9860C4A5B4Q37857045-55C69542-124E-4283-9C40-B830EFCF9AB3Q37976970-39DFCAE1-E15D-4171-970E-4C58EB1D2CCFQ38191658-A3380296-CB35-45C7-B0C3-833450850DABQ38282228-B047671C-BA78-4A09-BDFD-A40954DAAAE9Q39013664-45F6B334-193E-4781-84CE-ADC5E93856BDQ40132412-26BE698E-CDCF-4C46-933B-19EC0BDD793CQ40457824-7ACAE818-E80F-4EB5-8C05-F5A0BBC63A13Q41900187-C5FA8EE8-D49D-493F-AB12-AF7C84B03384Q42201543-FF5EE5E9-A2A7-4815-82EC-69BADAD28C44Q42250805-E32A9A56-93A5-4FA5-8AB2-13F14CD78BF5Q42666198-2036174E-4D53-4B8D-9B2B-71C49512DDDEQ43277441-CE5B1BDA-EB48-4B19-96CA-C33203AF0B14Q45030458-4D68D41E-7586-4D6D-A922-2F43DEADDB19Q45918480-0C75E8A5-BF26-4D1F-8563-CDF2CDDC2D6AQ46378683-D61BB800-70DB-4E35-9C91-5BC4C1D12D97
P2860
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@ast
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@en
type
label
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@ast
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@en
prefLabel
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@ast
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@en
P2093
P1476
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
@en
P2093
Fadi A El-Atat
James R Sowers
Sameer N Stas
Samy I McFarlane
P304
P356
10.1097/01.ASN.0000133698.80390.37
P577
2004-11-01T00:00:00Z